PloS one
Patient characteristics associated with the need for high doses of tenapanor hydrochloride in dialysis patients with hyperphosphatemia: A pooled analysis of three clinical trials
Abstract
The original clinical trials were registered at ClinicalTrials.gov under the identifiers NCT04767581, NCT04766398, and NCT04766385.
Keywords
- Humans
- Hyperphosphatemia
- Renal Dialysis
- Sulfonamides
Source
Published in PloS one. The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
At a glance
- Journal
- PloS one
- Type
- Clinical trial
- Published
- 28 August 2026
- Specialty
- Nephrology
- Read time
- 1 min
- PubMed
- 42664364